Cormedics platform technology has important new applications in electrophysiology, pericardial effusion, atrial fibrillation, ventricular closure, high frequency ultrasound (HIFU), stem cell and drug delivery.
Unlike conventional methods that treat the heart systemically and therefore involve all the body’s organs, intrapericardial therapy selectively treats heart disease by accessing the pericardial space using the minimally invasive PeriPort® device.
Intrapericardial approaches provide low risk, targeted access to the whole-heart for simple, effective and minimally invasive surgical delivery of a variety of therapies…compared with risking laceration with a bare Touhy needle.
• For pericardial effusion and drug delivery
• Regeneration with a proprietary stem cell delivery system.
• Therapeutic guidewire delivery for electrophysiology, atrial fibrillation, ventricular closure, and HIFU applications.